An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program
Chronic lymphatic leukemia (CLL) is the most frequent type of leukemia in western countries and when association with del(11q) is correlated with a worse prognosis. We reported the clinical case of an 80-year-old patient with CLL related to del(11q) and a BMI of 16.4 kg/m<sup>2</sup>, wh...
Main Authors: | Antonello Sica, Caterina Sagnelli, Alfonso Papa, Massimo Ciccozzi, Evangelista Sagnelli, Armando Calogero, Erika Martinelli, Beniamino Casale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/17/6/1929 |
Similar Items
-
Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia
by: Khan M, et al.
Published: (2017-03-01) -
Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.
by: John Xie, et al.
Published: (2021-01-01) -
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
by: Ujjani C, et al.
Published: (2020-08-01) -
Ibrutinib dose modifications in the management of CLL
by: Camille Hardy-Abeloos, et al.
Published: (2020-06-01) -
Imbruvica (Ibrutinib) induced subcutaneous hematoma: A case report
by: Chinmay Jani, et al.
Published: (2021-03-01)